• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    18 Stocks Moving in Thursday's Pre-Market Session

    6/9/22 6:13:02 AM ET
    $AKBA
    $ALNA
    $AXU
    $CALA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKBA alert in real time by email

    Gainers

    • View, Inc. (NASDAQ:VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares rose 16.7% to $0.56 in pre-market trading after jumping around 32% on Wednesday.
    • Smart for Life, Inc. (NASDAQ:SMFL) rose 14.8% to $0.51 in pre-market trading. Smart for Life is on track to close pending acquisition of Ceautamed Worldwide.
    • Hemisphere Media Group, Inc. (NASDAQ:HMTV) shares rose 14.7% to $8.03 in pre-market trading. Edenbrook Capital sent letter to Hemisphere Media Group Special Committee.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) rose 13.6% to $0.7955 in pre-market trading. Rigel Pharmaceuticals shares dipped 60% on Wednesday after the company announced data from the FORWARD Phase 3 clinical trial did not demonstrate statistical significance in the primary efficacy endpoint.
    • Akebia Therapeutics, Inc. (NASDAQ:AKBA) rose 8.2% to $0.4816 in pre-market trading.
    • comScore, Inc. (NASDAQ:SCOR) rose 7.8% to $2.35 in pre-market trading.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) rose 6.6% to $0.7992 in pre-market trading after jumping around 27% on Wednesday.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) rose 6.4% to $0.1261 in pre-market trading after gaining over 5% on Wednesday.
    • Alexco Resource Corp. (NYSE:AXU) rose 6.1% to $0.88 in pre-market trading.
    • Oxford Industries, Inc. (NYSE:OXM) rose 5.2% to $96.66 in pre-market trading as the company reported better-than-expected results for its first quarter and raised its FY22 guidance.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Qutoutiao Inc. (NASDAQ:QTT) shares fell 21.5% to $1.28 in pre-market trading after jumping more than 70% on Wednesday.
    • India Globalization Capital, Inc. (NYSE:IGC) shares fell 17.4% to $0.6770 in pre-market trading after jumping 93% on Wednesday. India Globalization Capital was granted U.S. patent titled 'Method And Composition For Treating Seizure Disorders (Such As Epilepsy).'
    • Symbotic (NASDAQ:SYM) fell 17.1% to $16.63 in pre-market trading after jumping around 120% on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.
    • Lottery.com Inc. (NASDAQ:LTRY) shares fell 8.8% to $1.65 in pre-market trading after jumping 11% on Wednesday.
    • Five Below, Inc. (NASDAQ:FIVE) fell 8.4% to $124.00 in pre-market trading. Five Below reported upbeat earnings for its first quarter, while sales missed estimates. The company also issued a weak forecast for the second quarter.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) fell 6.1% to $0.22 in pre-market trading after jumping 17% on Wednesday.
    • Energy Focus, Inc. (NASDAQ:EFOI) fell 5.6% to $2.55 in pre-market trading after jumping around 18% on Wednesday. The company recently announced a $3.5 million private placement priced at-the-market under Nasdaq rules.
    Get the next $AKBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKBA
    $ALNA
    $AXU
    $CALA

    CompanyDatePrice TargetRatingAnalyst
    Five Below Inc.
    $FIVE
    2/4/2026$233.00Underperform → Buy
    BofA Securities
    Five Below Inc.
    $FIVE
    1/13/2026$210.00Buy → Hold
    Jefferies
    Oxford Industries Inc.
    $OXM
    1/13/2026$35.00 → $40.00Market Perform
    Telsey Advisory Group
    Five Below Inc.
    $FIVE
    1/13/2026$195.00 → $240.00Outperform
    Telsey Advisory Group
    Five Below Inc.
    $FIVE
    1/8/2026$242.00Hold → Buy
    Deutsche Bank
    Oxford Industries Inc.
    $OXM
    12/11/2025$52.00 → $35.00Market Perform
    Telsey Advisory Group
    Five Below Inc.
    $FIVE
    12/8/2025$216.00Hold → Buy
    Truist
    Five Below Inc.
    $FIVE
    12/4/2025$170.00 → $195.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $AKBA
    $ALNA
    $AXU
    $CALA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Mukunda Ram converted options into 50,000 shares (SEC Form 4)

    4 - IGC Pharma, Inc. (0001326205) (Issuer)

    2/4/26 5:31:07 PM ET
    $IGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, Chief Commercial Officer Santos David A covered exercise/tax liability with 5,718 shares, decreasing direct ownership by 11% to 46,986 units (SEC Form 4)

    4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)

    2/4/26 4:21:41 PM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & Chief Financial Officer Schorno Dean L covered exercise/tax liability with 5,488 shares, decreasing direct ownership by 8% to 59,247 units (SEC Form 4)

    4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)

    2/4/26 4:21:11 PM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ALNA
    $AXU
    $CALA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Huang Chiao Chieh bought $600,001 worth of shares (262,009 units at $2.29), increasing direct ownership by 23% to 1,421,219 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    12/31/25 9:21:21 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    CEO and President Chubb Thomas Caldecot Iii bought $175,585 worth of shares (5,000 units at $35.12), increasing direct ownership by 28% to 22,709 units (SEC Form 4)

    4 - OXFORD INDUSTRIES INC (0000075288) (Issuer)

    12/12/25 5:52:12 PM ET
    $OXM
    Garments and Clothing
    Industrials

    Chief Executive Officer Huang Chiao Chieh bought $500,000 worth of shares (264,550 units at $1.89), increasing direct ownership by 30% to 1,159,210 units (SEC Form 4)

    4 - ENERGY FOCUS, INC/DE (0000924168) (Issuer)

    8/19/25 6:04:55 AM ET
    $EFOI
    Building Products
    Consumer Discretionary

    $AKBA
    $ALNA
    $AXU
    $CALA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VAFSEO issued to AKEBIA THERAPEUTICS INC

    Submission status for AKEBIA THERAPEUTICS INC's drug VAFSEO (ORIG-1) with active ingredient VADADUSTAT has changed to 'Approval' on 03/27/2024. Application Category: NDA, Application Number: 215192, Application Classification: Type 1 - New Molecular Entity

    3/28/24 10:46:38 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ALNA
    $AXU
    $CALA
    SEC Filings

    View All

    SEC Form 8-K filed by Five Below Inc.

    8-K - FIVE BELOW, INC (0001177609) (Filer)

    2/9/26 4:32:55 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 6-K filed by Imperial Petroleum Inc.

    6-K - Imperial Petroleum Inc./Marshall Islands (0001876581) (Filer)

    2/9/26 9:23:26 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Rigel Pharmaceuticals Inc.

    SCHEDULE 13G - RIGEL PHARMACEUTICALS INC (0001034842) (Subject)

    2/9/26 8:02:28 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ALNA
    $AXU
    $CALA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Imperial Petroleum Announces $10 Million Share Repurchase Program

    ATHENS, Greece, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (NASDAQ:IMPP) (the "Company") today announced that its Board of Directors has approved a share repurchase program and authorized the officers of the Company to repurchase, from time to time, up to $10,000,000 of the Company's common stock. Shares may be purchased in open market or privately negotiated transactions, at times and prices that are considered to be appropriate by the Company, and the program may be suspended or discontinued at any time. About Imperial Petroleum Inc. IMPERIAL PETROLEUM INC. is a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services. The

    2/9/26 9:20:00 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

    CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that members of its executive team will participate in a Fireside Chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12 at 9:30 AM EST. A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com following the conference. The Emerging Outlook: Biotech Summit hosted by Guggenheim Securities, LLC, will take place February 11-12, in New York City. About Akebia Therapeutics Akebia Therap

    2/4/26 8:00:00 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKBA
    $ALNA
    $AXU
    $CALA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Five Below upgraded by BofA Securities with a new price target

    BofA Securities upgraded Five Below from Underperform to Buy and set a new price target of $233.00

    2/4/26 8:24:40 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Five Below downgraded by Jefferies with a new price target

    Jefferies downgraded Five Below from Buy to Hold and set a new price target of $210.00

    1/13/26 9:05:21 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Oxford Industries with a new price target

    Telsey Advisory Group reiterated coverage of Oxford Industries with a rating of Market Perform and set a new price target of $40.00 from $35.00 previously

    1/13/26 8:19:44 AM ET
    $OXM
    Garments and Clothing
    Industrials

    $AKBA
    $ALNA
    $AXU
    $CALA
    Leadership Updates

    Live Leadership Updates

    View All

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Five Below Appoints Chief Financial Officer and Chief Merchandising Officer

    PHILADELPHIA, PA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE) ("Five Below" or "the Company"), the trend-right, high-quality, extreme-value retailer for the kid and the kid in all of us, today announced the appointments of Daniel Sullivan as Chief Financial Officer (CFO) and Michelle Israel as Chief Merchandising Officer (CMO), effective October 6, 2025. Both executives will report to Winnie Park, Chief Executive Officer. Mr. Sullivan will be responsible for Five Below's financial operations and related strategies, overseeing its Finance, Information Technology and Asset Protection teams. Ms. Israel will be responsible for Merchandising, Planning, Allocation, Product S

    10/1/25 9:25:00 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Lottery.com Appoints Acclaimed Actor and Director Tamer Hassan as President of Sports.com Studios

    LONDON, June 17, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (NASDAQ:LTRY, LTRYW)) ("Lottery.com" or "the Company"), a leading technology company transforming the intersection of gaming, sports and entertainment, today announced the appointment of internationally celebrated actor, producer, and entrepreneur Tamer Hassan as President of Sports.com Studios, its newly formed content division focused on film, docuseries, and original programming. A Director for Lottery.com since June 2023, Mr. Hassan brings a distinguished career spanning over 25 years in international film and television. He is widely known for iconic roles in productions such as Layer Cake, The Business, The Football Factory,

    6/17/25 3:25:40 PM ET
    $LTRY
    Computer Software: Prepackaged Software
    Technology

    $AKBA
    $ALNA
    $AXU
    $CALA
    Financials

    Live finance-specific insights

    View All

    Rigel Provides Business Update and 2026 Outlook

    Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues of $4.4 millionIn the dose escalation phase of the Phase 1b study of R289 in patients with lower-risk MDS, R289 continues to be generally well tolerated. RBC-TI was achieved by 33% (6/18) of evaluable transfusion dependent patients receiving R289 doses ≥500 mg QD, including 40% (2/5) in the 500 mg BID dose groupEnrollment in the dose expansion phase of the Phase 1b study is ongoing and Rigel is on track to complete enrollment and select the recommended Phase 2 dose for future clinical studies in the second half of 20262026 Outlook: Rigel anticipates

    1/12/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Comscore Completes Recapitalization Transaction with Preferred Stockholders Following Approval from Common Stockholders

    Transaction Provides Greater Financial Flexibility to Drive Long-Term GrowthEliminates Annual Preferred Dividend of $18 MillionStrengthens Corporate Governance and Realignment Among Stockholders RESTON, Va., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Comscore, Inc. (NASDAQ:SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today announced that the Company completed its recapitalization transaction with its preferred stockholders (Charter Communications, Liberty Broadband Corporation, and an affiliate of Cerberus Capital Management) on December 29, 2025, following approval by the Company's common stockholders at a special meeting held on December 19, 2025. Jo

    1/6/26 7:00:00 AM ET
    $SCOR
    Real Estate

    Imperial Petroleum Inc. Reports Third Quarter and Nine Months 2025 Financial and Operating Results

    ATHENS, Greece, Dec. 11, 2025 (GLOBE NEWSWIRE) -- IMPERIAL PETROLEUM INC. (NASDAQ:IMPP, the "Company")), a ship-owning company providing petroleum products, crude oil and dry bulk seaborne transportation services, announced today its unaudited financial and operating results for the third quarter and nine months ended September 30, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Full integration of our seven drybulk vessels within Q3 25' leading to a 36.1% increase of fleet calendar days compared to Q2 25'.Fleet operational utilization of 88.7% for Q3 25' versus 65.6% in in Q3 24'.Operational utilization for Q3 25' was 92.5% for our drybulk fleet and 84.4% for our tanker fleet.About 75% of to

    12/11/25 9:20:00 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    $AKBA
    $ALNA
    $AXU
    $CALA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Kiora Pharmaceuticals Inc.

    SC 13G/A - KIORA PHARMACEUTICALS INC (0001372514) (Subject)

    11/14/24 7:17:24 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Smart for Life Inc.

    SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

    11/14/24 6:49:12 PM ET
    $SMFL
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Rigel Pharmaceuticals Inc.

    SC 13G/A - RIGEL PHARMACEUTICALS INC (0001034842) (Subject)

    11/14/24 5:18:08 PM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care